# Naproxen Sodium and Diphenhydramine HCl

NDC: 62207-814
Generic name: Naproxen Sodium and Diphenhydramine HCl
Labeler / Manufacturer: Granules India Ltd
Product type: HUMAN OTC DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20210220

FDA application: ANDA213663

## Active ingredients

- DIPHENHYDRAMINE HYDROCHLORIDE: 25 mg/1
- NAPROXEN SODIUM: 220 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"62207-814"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=62207-814
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0d59780a-ef22-4b67-8b42-9795dbec8db0